Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

147 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Venoarterial extracorporeal membrane oxygenation in patients with infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials.
Zeymer U, Freund A, Hochadel M, Ostadal P, Belohlavek J, Rokyta R, Massberg S, Brunner S, Lüsebrink E, Flather M, Adlam D, Bogaerts K, Banning A, Sabaté M, Akin I, Jobs A, Schneider S, Desch S, Thiele H. Zeymer U, et al. Among authors: bogaerts k. Lancet. 2023 Oct 14;402(10410):1338-1346. doi: 10.1016/S0140-6736(23)01607-0. Epub 2023 Aug 26. Lancet. 2023. PMID: 37643628
Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial.
Banning AS, Sabaté M, Orban M, Gracey J, López-Sobrino T, Massberg S, Kastrati A, Bogaerts K, Adriaenssens T, Berry C, Erglis A, Haine S, Myrmel T, Patel S, Buera I, Sionis A, Vilalta V, Yusuff H, Vrints C, Adlam D, Flather M, Gershlick AH. Banning AS, et al. Among authors: bogaerts k. EuroIntervention. 2023 Aug 21;19(6):482-492. doi: 10.4244/EIJ-D-23-00204. EuroIntervention. 2023. PMID: 37334659 Free article. Clinical Trial.
A randomized controlled trial comparing conservative versus surgical treatment in patients with foot drop due to peroneal nerve entrapment: results of an internal feasibility pilot study.
Oosterbos C, Rummens S, Bogaerts K, Van Hoylandt A, Hoornaert S, Weyns F, Dubuisson A, Ceuppens J, Schuind S, Groen JL, Lemmens R, Theys T. Oosterbos C, et al. Among authors: bogaerts k. Pilot Feasibility Stud. 2023 Oct 31;9(1):181. doi: 10.1186/s40814-023-01407-x. Pilot Feasibility Stud. 2023. PMID: 37908016 Free PMC article.
The DAWN antivirals trial: process evaluation of a COVID-19 trial in general practice.
Tare D, Coenen S, De Sutter A, Heytens S, Devroey D, Buret L, Schoenmakers B, Delvaux N, Verbakel JY, Bogaerts K, van den Bruel A. Tare D, et al. Among authors: bogaerts k. BJGP Open. 2024 Apr 17:BJGPO.2023.0109. doi: 10.3399/BJGPO.2023.0109. Online ahead of print. BJGP Open. 2024. PMID: 37984980 Free article.
Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial.
Spaulding C, Krackhardt F, Bogaerts K, Urban P, Meis S, Morice MC, Eccleshall S. Spaulding C, et al. Among authors: bogaerts k. Am Heart J. 2023 Apr;258:77-84. doi: 10.1016/j.ahj.2023.01.007. Epub 2023 Jan 13. Am Heart J. 2023. PMID: 36642225 Free article. Clinical Trial.
STREAM-2: Half-Dose Tenecteplase or Primary Percutaneous Coronary Intervention in Older Patients With ST-Segment-Elevation Myocardial Infarction: A Randomized, Open-Label Trial.
Van de Werf F, Ristić AD, Averkov OV, Arias-Mendoza A, Lambert Y, Kerr Saraiva JF, Sepulveda P, Rosell-Ortiz F, French JK, Musić LB, Vandenberghe K, Bogaerts K, Westerhout CM, Pagès A, Danays T, Bainey KR, Sinnaeve P, Goldstein P, Welsh RC, Armstrong PW; STREAM-2 Investigators. Van de Werf F, et al. Among authors: bogaerts k. Circulation. 2023 Aug 29;148(9):753-764. doi: 10.1161/CIRCULATIONAHA.123.064521. Epub 2023 Jul 13. Circulation. 2023. PMID: 37439219 Clinical Trial.
Safety and efficacy of the latest generation biodegradable polymer-coated ultrathin sirolimus-eluting stent in the treatment of coronary artery disease in a European all-comer population with or without high bleeding risk: The Cruz HBR Registry.
Leistner DM, Rampat R, Haude M, Schmitz T, Allali A, Möllmann H, Stähli BE, Rudolph TK, Lauten A, Koning R, Bogaerts K, Sudhir K, Naber C. Leistner DM, et al. Among authors: bogaerts k. Minerva Cardiol Angiol. 2024 May 27. doi: 10.23736/S2724-5683.24.06462-7. Online ahead of print. Minerva Cardiol Angiol. 2024. PMID: 38804621
147 results